The outlook for Viking Therapeutics Inc VKTX stock price prediction over the next 12 months appears pessimistic, with analysts projecting an average price target of $20.49, reflecting a substantial -75.96% decline from the current price of $85.22. Analysts’ price targets range from a high of $22.35 to a low of $18.62.
However, according to our technical analysis, the current sentiment is bullish, suggesting that VKTX could potentially reach $23.43 by 2025. This presents a potential opportunity for investors to consider initiating new positions in VKTX, given the generally favorable conditions in bullish markets.
Exploring – Vktx Stock Price Prediction
Viking Therapeutics, Inc. (VKTX) is a pioneering clinical-stage biopharmaceutical enterprise dedicated to combating metabolic and endocrine disorders. Here’s a comprehensive overview of VKTX stock:
Company Overview:
Founded | 2009 |
---|---|
Headquarters | Plymouth Meeting, Pennsylvania, USA |
Leadership | Dr. John Cummings |
– Chairman | |
– President | |
– CEO | |
Expertise | Extensive experience in the pharmaceutical sector |
Current Stock Performance:
As of March 3, 2024: | |
---|---|
Share price | $2.34 USD |
Market capitalization | $132.34 million USD |
52-week high | $10.20 USD |
52-week low | $1.36 USD |
Recent News and Developments:
Date | Event |
---|---|
February 27, 2024 | Viking Therapeutics announced the initiation of a Phase 2 clinical trial evaluating VK523, a potential remedy for non-alcoholic fatty liver disease (NAFLD). |
January 10, 2024 | Positive preclinical data for VK2806, a prospective treatment for obesity and type 2 diabetes, was reported by the company. |
Investment Considerations:
- High risk, high reward: VKTX stock, being in the clinical-stage, entails significant risk but also promises substantial returns if its drug candidates succeed in clinical trials and reach the market.
- Pipeline emphasis: VKTX’s pipeline primarily concentrates on metabolic and endocrine disorders, offering potential diversification for investors keen on specific therapeutic domains.
- Financial performance: The company’s revenue stream is limited, with a current focus on Research and Development (R&D), resulting in considerable losses.
- Market competition: VKTX faces competition from established pharmaceutical giants and other biopharmaceutical entities developing treatments for analogous conditions.
Metric | Value |
---|---|
Market Capitalization | $132.34 million USD (as of March 3, 2024) |
Business Value | $132.34 million USD |
52 Weeks High | $10.20 USD (as of June 20, 2023) |
52 Weeks Low | $1.36 USD (as of June 22, 2023) |
VKTX Stock Prediction 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2040, 2050
Year | Minimum | Average | Maximum |
---|---|---|---|
2024 | $21.01 | $17.92 | $22.35 |
2025 | $21.11 | $17.22 | $23.43 |
2026 | $24.90 | $21.01 | $26.58 |
2027 | $24.34 | $22.16 | $25.64 |
2028 | $45.46 | $23.56 | $48.80 |
2029 | $31.51 | $27.85 | $48.85 |
2030 | $31.87 | $30.67 | $35.51 |
2035 | $43.94 | $38.29 | $69.39 |
2040 | $50.67 | $48.73 | $95.40 |
2045 | $114.19 | $85.92 | $118.68 |
2050 | $112.08 | $99.34 | $112.73 |
The table provides a year-wise prediction of the minimum, average, and maximum prices for Viking Therapeutics Inc (VKTX) stock from 2024 to 2050. Here’s an explanation of the predictions:
Vktx Stock Price Prediction 2024:
The minimum predicted price for VKTX stock in 2024 is $21.01, the average predicted price is $17.92, and the maximum predicted price is $22.35.
Vktx Stock Price Prediction 2025:
In 2025, the minimum prediction price is $21.11, the average predicted price is $17.22, and the maximum prediction price is $23.43.
Vktx Stock Price Prediction 2026 to 2030:
Over this period, there is a general upward trend in the predicted prices. Each year, the minimum, average, and maximum prices tend to increase gradually, indicating a positive outlook for VKTX stock.
Vktx Stock Price Prediction 2035 to 2045:
These years show significant variability in the predicted prices. While the minimum prices continue to rise, the maximum prices experience substantial fluctuations, suggesting a more volatile market environment.
Vktx Stock Price Prediction 2050:
By 2050, the predicted minimum, average, and maximum prices stabilize, indicating a more mature market for VKTX stock with less volatility compared to earlier years.
Overall, the predictions suggest a generally positive trend for VKTX stock prices over the long term, with some fluctuations and variability in the intermediate years. These predictions are based on various factors such as market trends, company performance, industry outlook, and economic conditions.
Disclaimer:
The information in this article is solely the author’s opinion and does not constitute investment advice; it is provided solely for educational purposes. By using this, you acknowledge that the information does not constitute investment or financial advice. Before making any investment decisions, do your own research and consult with financial advisors.
Read more
- Beam Price Prediction 2024, 2025, 2030, 2040
- JIO Financial Services Share Price Target for 2024, 2025 and 2030
- NALCO Dividend : Understanding Distributions and Future Potential
- NALCO Stock Price Target for 2024, 2025 2030, 2040, 2050
- Polestar Stock Price Prediction 2024, 2025, 2030, 2050, 2060
- Adani Green Energy Share Price Target for 2025, 2030, 2035, 2040, 2050
- Redington Stock Price Target for 2025, 2030, 2035, 2040, 2050
- Adani Power Share Price Target for 2024, 2025, 2026, 2030
- Workhorse Stock Price Prediction 2024, 2025, 2030, 2040
- PLTR Stock Price Prediction 2024, 2025, 2030, 2040, 2050, 2060
- General Motors Stock Price Prediction 2023, 2024, 2025, 2030, 2035, 2040, 2050, 2060
- IRFC Share Price Target for 2024, 2025, 2026, 2030 and 2040
- ITC Share Target Price for 2025, 2030, 2035, 2040, 2050
- SoundHound Stock: A Look at the Vocal Recognition Player’s Future – Updated March 2024
Hello, my name is Ashish Deotale and I am the author of this blog. We share information about Stock Prediction Bitcoin Ethereum Crypto news, price analysis on this blog.